Is Endoscopic Ultrasound-Fine Needle Aspiration for Ki67 Aspirational Enough?

Overview

Journal Clin Endosc

Date 2020 Mar 12

PMID 32156105

Authors

Yakira David

Michelle Kang Kim

Affiliations

Soon will be listed here.

References

Cui Y, Khanna L, Saqi A, Crapanzano J, Mitchell J, Sethi A . The Role of Endoscopic Ultrasound-Guided Ki67 in the Management of Non-Functioning Pancreatic Neuroendocrine Tumors. Clin Endosc. 2019; 53(2):213-220. PMC: 7137561. DOI: 10.5946/ce.2019.068. View

Falconi M, Eriksson B, Kaltsas G, Bartsch D, Capdevila J, Caplin M . ENETS Consensus Guidelines Update for the Management of Patients with Functional Pancreatic Neuroendocrine Tumors and Non-Functional Pancreatic Neuroendocrine Tumors. Neuroendocrinology. 2016; 103(2):153-71. PMC: 4849884. DOI: 10.1159/000443171. View

Leeds J, Nayar M, Bekkali N, Wilson C, Johnson S, Haugk B . Endoscopic ultrasound-guided fine-needle biopsy is superior to fine-needle aspiration in assessing pancreatic neuroendocrine tumors. Endosc Int Open. 2019; 7(10):E1281-E1287. PMC: 6773621. DOI: 10.1055/a-0990-9611. View

Hasegawa T, Yamao K, Hijioka S, Bhatia V, Mizuno N, Hara K . Evaluation of Ki-67 index in EUS-FNA specimens for the assessment of malignancy risk in pancreatic neuroendocrine tumors. Endoscopy. 2013; 46(1):32-8. DOI: 10.1055/s-0033-1344958. View

Halfdanarson T, Rabe K, Rubin J, Petersen G . Pancreatic neuroendocrine tumors (PNETs): incidence, prognosis and recent trend toward improved survival. Ann Oncol. 2008; 19(10):1727-33. PMC: 2735065. DOI: 10.1093/annonc/mdn351. View

Martin-Perez E, Capdevila J, Castellano D, Jimenez-Fonseca P, Salazar R, Beguiristain-Gomez A . Prognostic factors and long-term outcome of pancreatic neuroendocrine neoplasms: Ki-67 index shows a greater impact on survival than disease stage. The large experience of the Spanish National Tumor Registry (RGETNE). Neuroendocrinology. 2013; 98(2):156-68. DOI: 10.1159/000355152. View

Panzuto F, Boninsegna L, Fazio N, Campana D, Brizzi M, Capurso G . Metastatic and locally advanced pancreatic endocrine carcinomas: analysis of factors associated with disease progression. J Clin Oncol. 2011; 29(17):2372-7. DOI: 10.1200/JCO.2010.33.0688. View

Shah M, Goldner W, Halfdanarson T, Bergsland E, Berlin J, Halperin D . NCCN Guidelines Insights: Neuroendocrine and Adrenal Tumors, Version 2.2018. J Natl Compr Canc Netw. 2018; 16(6):693-702. DOI: 10.6004/jnccn.2018.0056. View

Larghi A, Capurso G, Carnuccio A, Ricci R, Alfieri S, Galasso D . Ki-67 grading of nonfunctioning pancreatic neuroendocrine tumors on histologic samples obtained by EUS-guided fine-needle tissue acquisition: a prospective study. Gastrointest Endosc. 2012; 76(3):570-7. DOI: 10.1016/j.gie.2012.04.477. View

10.

Strosberg J, Halfdanarson T, Bellizzi A, Chan J, Dillon J, Heaney A . The North American Neuroendocrine Tumor Society Consensus Guidelines for Surveillance and Medical Management of Midgut Neuroendocrine Tumors. Pancreas. 2017; 46(6):707-714. PMC: 5642985. DOI: 10.1097/MPA.0000000000000850. View

11.

Yang G, Ji M, Chen J, Chen R, Chen Y, Fu D . Surgery management for sporadic small (≤2 cm), non-functioning pancreatic neuroendocrine tumors: a consensus statement by the Chinese Study Group for Neuroendocrine Tumors (CSNET). Int J Oncol. 2016; 50(2):567-574. DOI: 10.3892/ijo.2016.3826. View